Beat Memo. New York lawmakers are looking to create transparency in a drug rebate program offered to hospitals serving low-income communities, with a state mandate to report how the federal ...

The 340B program has ballooned in size since it was established in 1994. As of February 2025, there are 60,000 provider organizations participating in the program, an increase of 600% since 2000.

MFN reinforces the worst incentives in 340B, shifts costs to patients and employers, and threatens the long-term health of both public programs and private enterprise.

Based in Odessa, Texas, the Odessa American was founded in 1940. Odessa American 700 N. Grant Ave., Suite 800 Odessa, TX 79761-4590 (432) 337-4661 ...

The Supreme Court offered some 340B relief – for now . In 2018, the Centers for Medicare & Medicaid Services (CMS) reduced payment rates for 340B drugs to average sales price minus 22.5%, ...

The 340B federal drug discount program was created in 1992 and is the second largest drug program in the country. It was designed to help reduce the financial burden of accessing medication for ...

The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...

Commentary: 340B is a tremendous federal program that ought to be fixed — by the federal government. A state initiative would make things worse. Times Union Logo Hearst Newspapers Logo ...

Expanding the unchecked 340B program is not the answer. While the State House voted to pass the bill last week, North Dakota’s Senate and governor can stop this disaster.

340B Prescription Drug Discounts Should Go Directly to Tennessean Patients’ Care. With the election behind us, voters have given policymakers a mandate for meaningful policy reforms.

340B funds help ensure that struggling safety-net hospitals do not have to reduce the provision of charity care, close relatively unprofitable departments, or in some cases even close completely.

Approximately one-third of New Jersey hospitals participate in the 340B-eligible program, serving some of our state’s vulnerable patients, including those with low incomes and no insurance.